The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Taking dendritic cells into medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Self-citationJaneway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., & Powrie, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070590 · Cited by 2,710
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi-Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,553
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
Self-citationDendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Cited by
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
“An important question regarding the immune privilege of the CNS is whether there exists a population of dendritic cells (DCs), the professional antigen-presenting cells (APCs) of the immune system (12).”
BackgroundImmunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Jin, R., Yang, G., & Li, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109766 · Cited by 1,521
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature Reviews Immunology · doi:10.1038/nri2569 · Cited by 1,379
Decisions About Dendritic Cells: Past, Present, and Future
Steinman, R. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100311-102839 · Cited by 1,274
Self-citationPrietl, B., Treiber, G., Pieber, T., & Amrein, K. (2013) · Nutrients · doi:10.3390/nu5072502 · Cited by 1,130
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Coussens, L. M., Zitvogel, L., & Palucka, A. K. (2013) · Science · doi:10.1126/science.1232227 · Cited by 1,079
Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C.-U., Siler, D. A., Arumugam, T. V., Orthey, E., Gerloff, C., Tolosa, E., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.534503 · Cited by 1,066
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Self-Healing Injectable Hydrogels for Tissue Regeneration
Bertsch, P., Diba, M., Mooney, D. J., & Leeuwenburgh, S. C. G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00179 · Cited by 892
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
Self-citationChiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838
Bachem, A., Güttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A., Movassaghi, K., Opitz, C., Mages, H. W., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100348 · Cited by 822
Deciphering the transcriptional network of the dendritic cell lineage
the Immunological Genome Consortium, Miller, J. C., Brown, B. D., Shay, T., Gautier, E. L., Jojic, V., Cohain, A., Pandey, G., Leboeuf, M., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2370 · Cited by 781
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Golden, E. B., Chhabra, A., Chachoua, A., Adams, S., Donach, M., Fenton-Kerimian, M., Friedman, K., Ponzo, F., Babb, J. S., Goldberg, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00054-6 · Cited by 667
Waskow, C., Liu, K., Darrasse-Jèze, G., Guermonprez, P., Ginhoux, F., Merad, M., Shengelia, T., Yao, K., & Nussenzweig, M. (2008) · Nature Immunology · doi:10.1038/ni.1615 · Cited by 665
Ceppi, M., Pereira, P. M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M. A., & Pierre, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811073106 · Cited by 631
Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.013 · Cited by 619
Self-citationYellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., Castro, E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082292 · Cited by 594
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Mitchell, D. A., Batich, K. A., Gunn, M. D., Huang, M.-N., Sanchez-Perez, L., Nair, S. K., Congdon, K. L., Reap, E. A., Archer, G. E., Desjardins, A., et al. (2015) · Nature · doi:10.1038/nature14320 · Cited by 531
Unravelling mononuclear phagocyte heterogeneity
Geissmann, F., Gordon, S., Hume, D. A., Mowat, A. M., & Randolph, G. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2784 · Cited by 529
Mechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
Sancho, D., Mourão-Sá, D., Joffre, O. P., Schulz, O., Rogers, N. C., Pennington, D. J., Carlyle, J. R., & Reis e Sousa, C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34584 · Cited by 519
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine
Manicassamy, S., Reizis, B., Ravindran, R., Nakaya, H., Salazar-Gonzalez, R. M., Wang, Y.-C., & Pulendran, B. (2010) · Science · doi:10.1126/science.1188510 · Cited by 500
Cancer immunotherapies: advances and bottlenecks
Rui, R., Zhou, L., & He, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212476 · Cited by 484
Dynamic profiling of the protein life cycle in response to pathogens
Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460
Anatomy of a Discovery: M1 and M2 Macrophages
Mills, C. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00212 · Cited by 449
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Xie, Y., Akpinarli, A., Maris, C., Hipkiss, E. L., Lane, M., Kwon, E.-K. M., Muranski, P., Restifo, N. P., & Antony, P. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091921 · Cited by 457
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Tran Janco, J. M., Lamichhane, P., Karyampudi, L., & Knutson, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403134 · Cited by 440
Survivin: a unique target for tumor therapy
Garg, H., Suri, P., Gupta, J. C., Talwar, G. P., & Dubey, S. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0326-1 · Cited by 437
Immunotherapy of cancer in 2012
Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., & Ferrone, S. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20132 · Cited by 436
Infection-mimicking materials to program dendritic cells in situ
Ali, O. A., Huebsch, N., Cao, L., Dranoff, G., & Mooney, D. J. (2009) · Nature Materials · doi:10.1038/nmat2357 · Cited by 434
Langerhans cells and more: langerin‐expressing dendritic cell subsets in the skin
Romani, N., Clausen, B. E., & Stoitzner, P. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00886.x · Cited by 431
Quintana, F. J., Murugaiyan, G., Farez, M. F., Mitsdoerffer, M., Tukpah, A.-M., Burns, E. J., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009201107 · Cited by 428
Phan, T. G., Green, J. A., Gray, E. E., Xu, Y., & Cyster, J. G. (2009) · Nature Immunology · doi:10.1038/ni.1745 · Cited by 425
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb, S., Königsrainer, A., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2639 · Cited by 421
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
Yamazaki, S., Dudziak, D., Heidkamp, G. F., Fiorese, C., Bonito, A. J., Inaba, K., Nussenzweig, M. C., & Steinman, R. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6923 · Cited by 418
Self-citationInjectable cryogel-based whole-cell cancer vaccines
Bencherif, S. A., Warren Sands, R., Ali, O. A., Li, W. A., Lewin, S. A., Braschler, T. M., Shih, T.-Y., Verbeke, C. S., Bhatta, D., Dranoff, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8556 · Cited by 416
New adjuvants for human vaccines
Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 406
Engineering Nano‐ and Microparticles to Tune Immunity
Moon, J. J., Huang, B., & Irvine, D. J. (2012) · Advanced Materials · doi:10.1002/adma.201200446 · Cited by 404
New Paradigms in Type 2 Immunity
Pulendran, B., & Artis, D. (2012) · Science · doi:10.1126/science.1221064 · Cited by 401
M1 and M2 Macrophages: The Chicken and the Egg of Immunity
Mills, C. D., & Ley, K. (2014) · Journal of Innate Immunity · doi:10.1159/000364945 · Cited by 401
Chemical vapor deposition growth of monolayer MoSe2 nanosheets
Shaw, J. C., Zhou, H., Chen, Y., Weiss, N. O., Liu, Y., Huang, Y., & Duan, X. (2014) · Nano Research · doi:10.1007/s12274-014-0417-z · Cited by 390
Geissmann, F., Auffray, C., Palframan, R., Wirrig, C., Ciocca, A., Campisi, L., Narni‐Mancinelli, E., & Lauvau, G. (2008) · Immunology & Cell Biology · doi:10.1038/icb.2008.19 · Cited by 385
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04006 · Cited by 385
Dendritic Cell and Macrophage Heterogeneity In Vivo
Hashimoto, D., Miller, J., & Merad, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.007 · Cited by 368
Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3
Yount, J. S., Moltedo, B., Yang, Y.-Y., Charron, G., Moran, T. M., López, C. B., & Hang, H. C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.405 · Cited by 367
Dendritic Cell–Based Cancer Vaccines
Santos, P. M., & Butterfield, L. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701024 · Cited by 361
Dendritic cell control of tolerogenic responses
Manicassamy, S., & Pulendran, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01015.x · Cited by 357
Liu, W. M., Fowler, D. W., Smith, P., & Dalgleish, A. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605465 · Cited by 356
Hydrogels and Scaffolds for Immunomodulation
Singh, A., & Peppas, N. A. (2014) · Advanced Materials · doi:10.1002/adma.201402105 · Cited by 355
Programming dendritic cells to induce TH2 and tolerogenic responses
Pulendran, B., Tang, H., & Manicassamy, S. (2010) · Nature Immunology · doi:10.1038/ni.1894 · Cited by 355
Liu, C., Liu, X., Xiang, X., Pang, X., Chen, S., Zhang, Y., Ren, E., Zhang, L., Liu, X., Lv, P., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01098-0 · Cited by 350
Xu, J., Kato, K., Raymond, E., Hubner, R. A., Shu, Y., Pan, Y., Park, S. R., Ping, L., Jiang, Y., Zhang, J., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00108-0 · Cited by 338
Genetic Variants Regulating Immune Cell Levels in Health and Disease
Orrù, V., Steri, M., Sole, G., Sidore, C., Virdis, F., Dei, M., Lai, S., Zoledziewska, M., Busonero, F., Mulas, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.041 · Cited by 337
Type 2 immunity: Expanding our view
Lloyd, C. M., & Snelgrove, R. J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1604 · Cited by 334
Dendritic cells in intestinal homeostasis and disease
Rescigno, M., & Di Sabatino, A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39134 · Cited by 327
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Resident and “Inflammatory” Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319
Huysamen, C., Willment, J. A., Dennehy, K. M., & Brown, G. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709923200 · Cited by 318
Tang, H., Cao, W., Kasturi, S. P., Ravindran, R., Nakaya, H. I., Kundu, K., Murthy, N., Kepler, T. B., Malissen, B., & Pulendran, B. (2010) · Nature Immunology · doi:10.1038/ni.1883 · Cited by 313
Regulatory Role of Dendritic Cells in Postinfarction Healing and Left Ventricular Remodeling
Anzai, A., Anzai, T., Nagai, S., Maekawa, Y., Naito, K., Kaneko, H., Sugano, Y., Takahashi, T., Abe, H., Mochizuki, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.052126 · Cited by 312
The innate immune system in SLE: type I interferons and dendritic cells
Rönnblom, L., & Pascual, V (2008) · Lupus · doi:10.1177/0961203308090020 · Cited by 312
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
Bigley, V., Haniffa, M., Doulatov, S., Wang, X.-N., Dickinson, R., McGovern, N., Jardine, L., Pagan, S., Dimmick, I., Chua, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101459 · Cited by 306
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
Pulendran, B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2629 · Cited by 305
New materials for tissue engineering: towards greater control over the biological response
Chan, G., & Mooney, D. J. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.03.011 · Cited by 305
Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 302
Manicassamy, S., Ravindran, R., Deng, J., Oluoch, H., Denning, T. L., Kasturi, S. P., Rosenthal, K. M., Evavold, B. D., & Pulendran, B. (2009) · Nature Medicine · doi:10.1038/nm.1925 · Cited by 302
Xiong, Y., Mi, B.-B., Lin, Z., Hu, Y.-Q., Yu, L., Zha, K.-K., Panayi, A. C., Yu, T., Chen, L., Liu, Z.-P., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00426-8 · Cited by 291
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life
Granot, T., Senda, T., Carpenter, D. J., Matsuoka, N., Weiner, J., Gordon, C. L., Miron, M., Kumar, B. V., Griesemer, A., Ho, S.-H., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.019 · Cited by 290
Immunological Aspects of Allogeneic Mesenchymal Stem Cell Therapies
Griffin, M. D., Ritter, T., & Mahon, B. P. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.156 · Cited by 289
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation
Niessen, F., Schaffner, F., Furlan-Freguia, C., Pawlinski, R., Bhattacharjee, G., Chun, J., Derian, C. K., Andrade-Gordon, P., Rosen, H., & Ruf, W. (2008) · Nature · doi:10.1038/nature06663 · Cited by 280
Dissecting cellular crosstalk by sequencing physically interacting cells
Giladi, A., Cohen, M., Medaglia, C., Baran, Y., Li, B., Zada, M., Bost, P., Blecher-Gonen, R., Salame, T.-M., Mayer, J. U., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0442-2 · Cited by 280
Kitamura, H., Ohno, Y., Toyoshima, Y., Ohtake, J., Homma, S., Kawamura, H., Takahashi, N., & Taketomi, A. (2017) · Cancer Science · doi:10.1111/cas.13332 · Cited by 278
Laoui, D., Keirsse, J., Morias, Y., Van Overmeire, E., Geeraerts, X., Elkrim, Y., Kiss, M., Bolli, E., Lahmar, Q., Sichien, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13720 · Cited by 277
Polymeric Materials for Gene Delivery and DNA Vaccination
Nguyen, D. N., Green, J. J., Chan, J. M., Langer, R., & Anderson, D. G. (2009) · Advanced Materials · doi:10.1002/adma.200801478 · Cited by 273
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.12956 · Cited by 265
HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells
Gringhuis, S. I., van der Vlist, M., van den Berg, L. M., den Dunnen, J., Litjens, M., & Geijtenbeek, T. B. H. (2010) · Nature Immunology · doi:10.1038/ni.1858 · Cited by 261
Proteomic Analysis of Two Types of Exosomes in Human Whole Saliva
Ogawa, Y., Miura, Y., Harazono, A., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., Yamaguchi, T., Toda, T., Endo, T., Tsubuki, M., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.13 · Cited by 259
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
Raker, V. K., Domogalla, M. P., & Steinbrink, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00569 · Cited by 259
Exosome-Like Vesicles with Dipeptidyl Peptidase IV in Human Saliva
Ogawa, Y., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., & Yanoshita, R. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1059 · Cited by 258
The Cancer Paradigm of Severe Pulmonary Arterial Hypertension
Rai, P. R., Cool, C. D., King, J. A. C., Stevens, T., Burns, N., Winn, R. A., Kasper, M., & Voelkel, N. F. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1369pp · Cited by 258
Modulation of adaptive immunity with Toll-like receptors
Manicassamy, S., & Pulendran, B. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.005 · Cited by 255
Olah, M., Biber, K., Vinet, J., & W.G.M. Boddeke, H. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794488575 · Cited by 254
Acute Inflammation in Tissue Healing
Soliman, A. M., & Barreda, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010641 · Cited by 254
Ballow, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 253
Széles, L., Keresztes, G., Töröcsik, D., Balajthy, Z., Krenács, L., Póliska, S., Steinmeyer, A., Zuegel, U., Pruenster, M., Rot, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803345 · Cited by 234
“Maturation is characterized by the migration of DCs to lymphoid organs, the down-regulation of Ag uptake, and an enhanced capacity for priming naive T cells (1, 2).”
BackgroundGastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
Lee, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3751 · Cited by 224
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II
Takamatsu, H., Takegahara, N., Nakagawa, Y., Tomura, M., Taniguchi, M., Friedel, R. H., Rayburn, H., Tessier-Lavigne, M., Yoshida, Y., Okuno, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1885 · Cited by 288
Immunomodulatory properties of mesenchymal stromal cells: an update
Müller, L., Tunger, A., Wobus, M., von Bonin, M., Towers, R., Bornhäuser, M., Dazzi, F., Wehner, R., & Schmitz, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.637725 · Cited by 205
“Dendritic Cells Activated DCs display a unique capacity to induce T-cell responses and are the main producers of proinflammatory cytokines (Steinman and Banchereau, 2007; Qian and Cao, 2018).”
Background
Metadata
- Authors
- Steinman, R. M., & Banchereau, J.
- Venue
- Nature
- Published
- 2007-09
- Volume
- 449
- Issue
- 7161
- Pages
- 419-426
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2062254683
- Cited by
- 2,127
- References
- 110
- FWCI
- 54.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.